- Description
- Benefits
- Risks
- Additional information
- Research
Description
Premium Ipamorelin is a high-purity synthetic pentapeptide classified as a growth hormone releasing peptide (GHRP), studied in laboratory environments for its role in growth hormone (GH) secretion, ghrelin receptor activation, and endocrine signalling pathways.
As a selective agonist of the growth hormone secretagogue receptor (GHS-R), Ipamorelin is widely investigated for its ability to stimulate targeted growth hormone release from the pituitary gland, with a focus on precision signalling within the GH axis.
This premium-grade variant is designed for research requiring enhanced purity, consistency, and reproducibility, making it suitable for advanced laboratory environments across Ireland and Europe.
Common research applications include:
- Growth hormone secretion and regulation models
- Ghrelin receptor (GHS-R) activation studies
- Endocrine and neuroendocrine pathway research
- Metabolic signalling and energy regulation analysis
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – Premium Ipamorelin
| Specification | Details |
|---|---|
| Product Name | Premium Ipamorelin |
| Compound Type | Synthetic pentapeptide |
| Functional Class | Growth hormone releasing peptide (GHRP) |
| Mechanism of Action | Selective ghrelin receptor (GHS-R) agonist |
| Biological Targets | Pituitary gland, GHS-R receptors |
| Amino Acid Length | 5 amino acids |
| Format | Lyophilised powder |
| Purity | High-purity research grade |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
esearched Benefits & Focus Areas – Premium Ipamorelin
1. Selective Growth Hormone (GH) Release Research
Premium Ipamorelin has been studied for:
- Targeted stimulation of endogenous GH release
- Investigation of pituitary gland signalling pathways
- Analysis of controlled hormonal secretion dynamics
Reference basis: Derived from endocrinology and pharmacology research examining selective GHRP activity and receptor-specific activation.
2. Ghrelin Receptor (GHS-R) Activation
Research has explored:
- Binding to growth hormone secretagogue receptors
- Targeted activation of ghrelin signalling pathways
- Reduced interaction with non-target biological systems (research context)
Reference basis: Based on biochemical studies investigating receptor selectivity in peptide-receptor interactions.
3. Endocrine Precision & GH Axis Research
Premium Ipamorelin is used in:
- Research into precise hormonal modulation
- Investigation of the GH/IGF-1 axis
- Studies on neuroendocrine signalling systems
Reference basis: Supported by clinical and preclinical studies examining endocrine system regulation and growth hormone pathway control.
4. High-Purity Research Applications
This premium variant supports:
- Improved reproducibility in experimental models
- Consistent peptide performance across studies
- Enhanced purity standards for laboratory research
Reference basis: Based on laboratory best practices emphasising purity and consistency in peptide research environments.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – Premium Ipamorelin
1. Hormonal System Influence
- May significantly affect growth hormone levels
- Potential for endocrine imbalance in research models
Reference basis: Based on studies examining GH regulation and endocrine feedback systems.
2. Receptor Interaction Complexity
- May influence multiple signalling pathways
- Potential for variable responses depending on experimental conditions
Reference basis: Derived from research into peptide-receptor binding and signalling complexity.
3. Off-Target Biological Effects
- Possible interaction with non-target systems
- Broad influence across neuroendocrine pathways
Reference basis: Based on studies highlighting interconnected signalling systems.
4. Limited Long-Term Research
- Lack of extensive long-term data
- Primarily studied in controlled laboratory environments
Reference basis: Reflects the current stage of growth hormone peptide research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS